Skip to main content
Earnings Labs
Compugen Ltd. logo

Compugen Ltd. (CGEN)

NASDAQ·Healthcare·Biotechnology

$2.00

+2.04%

Mkt Cap $198.56M

Analyst Ratings

Buy

1

Hold

0

Sell

0

Price Target (5 analysts)

$5.00

Range $5.00 – $5.00

Implied Upside

+150.0%

Consensus $5.00 vs current $2.00